Larvol Delta - CS0159-in-Chinese-Patients-With-PSC-Primary-Sclerosing-Cholangitis

linafexor (CS0159) - Cascade Pharma

http://clinicaltrials.gov/ct2/show/NCT05896137

Mar 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next